Tideglusib 10mg 10mg | Purity Not Available
Adooq Bioscience
Tideglusib is a GSK-3 inhibitor currently in phase II clinical trials for the treatment of Alzheimer disease and progressive supranuclear palsy
More Information Supplier PageSearch Results
Tedizolid (TR-701) 50mg 50mg | Purity Not Available
Adooq Bioscience
Tedizolid (TR-701) 5mg 5mg | Purity Not Available
Adooq Bioscience
Tedizolid (TR-701) 25mg 25mg | Purity Not Available
Adooq Bioscience
Tedizolid (TR-701) 10mg 10mg | Purity Not Available
Adooq Bioscience
T-705 (Favipiravir) 50mg 50mg | Purity Not Available
Adooq Bioscience
T-705, a substituted pyrazine compound, has been found to exhibit potent anti-influenza virus activity in vitro and in vivo.
More Information Supplier PageT-705 (Favipiravir) 25mg 25mg | Purity Not Available
Adooq Bioscience
T-705, a substituted pyrazine compound, has been found to exhibit potent anti-influenza virus activity in vitro and in vivo.
More Information Supplier PageT-705 (Favipiravir) 100mg 100mg | Purity Not Available
Adooq Bioscience
T-705, a substituted pyrazine compound, has been found to exhibit potent anti-influenza virus activity in vitro and in vivo.
More Information Supplier PageT-705 (Favipiravir) 10mg 10mg | Purity Not Available
Adooq Bioscience
T-705, a substituted pyrazine compound, has been found to exhibit potent anti-influenza virus activity in vitro and in vivo.
More Information Supplier PageTAK-715 50mg 50mg | Purity Not Available
Adooq Bioscience
TAK 715 an inhibitor of p38 MAPK (IC50 = 7.1 nM for p38 MAPK??), Wnt/beta-catenin signaling, and Inhibits 22 kinases by more than 80%, including CK 1??/??.
More Information Supplier Page